DAWN ZARATIEGUI: Open Payments
NPI 1922484856 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,013 in 34 payments from 7 companies in 2025. Trend: 2023 $393 · 2024 $678 · 2025 $1,013
Food & beverage: $960Education: $53
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 16 | $426 |
| Regeneron Healthcare Solutions, Inc. | 10 | $377 |
| Optinose US, Inc. | 2 | $55 |
| SANOFI-AVENTIS U.S. LLC | 1 | $53 |
| GlaxoSmithKline, LLC. | 2 | $44 |
| Amgen Inc. | 2 | $39 |
| Stryker Corporation | 1 | $19 |
Products named: DUPIXENT, Xhance, NUCALA, LIBTAYO, TEZSPIRE, CLARIFIX.
Industry payments across NV — which companies pay providers there.
